You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

UGT polymorphism

Showing 1 - 25 of 758
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in Kaohsiung (UGT1A1 genotyping (6,6), UGTIA1 genotyping (6,7), UGTIA1 genotyping (7,7))

Completed
  • Metastatic Colorectal Cancer
  • UGT1A1 genotyping (6,6)
  • +7 more
  • Kaohsiung, Taiwan
    Chung-Ho Memorial Hospital, Kaohsiung Medical University:
Nov 9, 2021

Pharmacogenomic, Pharmacokinetics Trial in Cairo (Empagliflozin 10 milligram)

Not yet recruiting
  • Pharmacogenomic
  • Pharmacokinetics
  • Empagliflozin 10 milligram
  • Cairo, Egypt
    Faculty of Pharmacy
Feb 5, 2022

First Line Metastatic Colorectal Cancer Trial in Beaumont, Clermont-Ferrand (Irinotecan)

Completed
  • First Line Metastatic Colorectal Cancer
  • Beaumont, France
  • +2 more
Dec 24, 2019

Colorectal Cancer Trial (bevacizumab, filgrastim, fluorouracil)

Completed
  • Colorectal Cancer
  • bevacizumab
  • +4 more
  • (no location specified)
Mar 27, 2020

Pharmacogenomics Trial (Indapamide 1.5 MG SR)

Not yet recruiting
  • Pharmacogenomics
  • Indapamide 1.5 MG SR
  • (no location specified)
Mar 15, 2022

Advanced Solid Tumors or Triple-negative Breast Cancer Trial in Japan (Sacituzumab Govitecan-hziy)

Recruiting
  • Advanced Solid Tumors or Triple-negative Breast Cancer
  • Sacituzumab Govitecan-hziy
  • Aichi, Japan
  • +21 more
Dec 1, 2022

Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)

Active, not recruiting
  • Adult Solid Neoplasm
  • Erlotinib Hydrochloride
  • Irinotecan Hydrochloride
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Xiao Chai Hu Tang, Irinotecan-induced Diarrhea Trial in Guangzhou (Xiao Chai Hu Tang (XCHT), Placebo, FOLFIRI/mXELIRI regimen)

Not yet recruiting
  • Xiao Chai Hu Tang
  • Irinotecan-induced Diarrhea
  • Xiao Chai Hu Tang (XCHT)
  • +3 more
  • Guangzhou, Guangdong, China
    Guangdong Provincial Hospital of Traditional Chinese Medicine
Sep 24, 2023

Non-cancerous Chronic Pain Trial in Nîmes (Pharmacogenetic analysis allowing personalized opioid prescription, Standard opioid

Not yet recruiting
  • Non-cancerous Chronic Pain
  • Pharmacogenetic analysis allowing personalized opioid prescription
  • Standard opioid prescription
  • Nîmes, France
    CHU Nimes
Jan 24, 2022

Genetic Factors Underlying Post-ERCP Pancreatitis

Not yet recruiting
  • Post-ERCP Acute Pancreatitis
  • Take blood samples
  • Nijmegen, Gelderland, Netherlands
    RadboudUMC
Feb 23, 2022

Immune System Disorder (Healthy Volunteers) Trial in Miami (Belumosudil, UGT1A1 victim drug, P-gp victim drug)

Completed
  • Immune System Disorder (Healthy Volunteers)
  • Miami, Florida
    Investigational Site Number: 8400001
Apr 11, 2023

CYP2C9*3 Polymorphism on Ibuprofen in Pakistani Population

Completed
  • Healthy Volunteers
  • Ibuprofen
  • Rawalpindi, Punjab, Pakistan
    Ammarah Amjad
Aug 1, 2023

Interaction Trial in Spokane (Diclofenac, curcumin)

Not yet recruiting
  • Interaction
  • Spokane, Washington
    Washington State University College of Pharmacy and Pharmaceutic
Sep 23, 2023

General Anesthesia Trial in Guangzhou (Propofol)

Recruiting
  • General Anesthesia
  • Guangzhou, Guangdong, China
    Nanfang Hospital，Southern Medical University
Jun 8, 2021

Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)

Completed
  • HIV Infections
    • Bangkok, Thailand
      HIV-NAT Thai Red Cross AIDS Research Center
    Jul 15, 2020

    Metastatic Colorectal Cancer Trial in Denmark, Germany, Spain (FOLFIRI Protocol, SCO-101)

    Recruiting
    • Metastatic Colorectal Cancer
    • Aalborg, Denmark
    • +11 more
    Feb 28, 2022

    Upper Gastrointestinal Tract of Crohn's Disease

    Completed
    • Crohn Disease
    • General variables
    • +3 more
    • Terrassa, Barcelona, Spain
      Hospital Universitari Mutua Terrassa
    May 23, 2023

    Advanced Biliary Tract Cancer, Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma Trial in Hangzhou (Irinotecan

    Not yet recruiting
    • Advanced Biliary Tract Cancer
    • +3 more
    • Irinotecan Liposome Injection
    • +3 more
    • Hangzhou, Zhejiang, China
      Cancer Hospital of the University of Chinese Academy of Sciences
    Sep 16, 2021

    Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic Trial (Irinotecan Liposome Injection, Fluorouracil, Leucovorin)

    Not yet recruiting
    • Pancreatic Cancer Non-resectable
    • Pancreatic Cancer Metastatic
    • Irinotecan Liposome Injection
    • +5 more
    • (no location specified)
    Sep 16, 2021

    Colorectal Cancer, Pancreatic Cancer Trial (Irinotecan)

    Recruiting
    • Colorectal Cancer
    • Pancreatic Cancer
    • Lexington, Kentucky
      University of Kentucky
    Oct 13, 2022

    Gastric/Colorectal Cancers

    Not yet recruiting
    • Gastric Cancer
    • Colo-rectal Cancer
    • quantitative Real-time PCR
    • (no location specified)
    Nov 27, 2023

    Effect of Gene Polymorphism on Cognitive Function

    Recruiting
    • Polymorphosis
    • Cognitive Function
    • High intensitiy interval training
    • Kaohsiung, Taiwan
      Kaohsiung Medical University
    May 25, 2023

    Atomoxetine PBPK-PD Clinical Study

    Completed
    • ADHD
    • Atomoxetine Hydrochloride
    • Kansas City, Missouri
      Children's Mercy Hospital and Clinics
    Jun 20, 2022

    Liver Transplant Rejection Trial in Cairo (gene polymorphism)

    Completed
    • Liver Transplant Rejection
    • gene polymorphism
    • Cairo, Egypt
      Sara Mohamed Mohamed
    Sep 24, 2023

    Clinical Significance and Coexistence of Polymorphisms of

    Active, not recruiting
    • Ligament; Laxity
    • Recurrent Patellar Dislocation
    • genetic test
    • Beighton joint laxity test
    • Lodz, Lodzkie Voivodeship, Poland
    • +1 more
    Feb 28, 2023